Syndax Pharmaceuticals announced inducement grants to five new employees on August 1, 2026, under NASDAQ Listing Rule 5635(c)(4). These grants allow employees to purchase up to 59,250 shares.
Syndax Pharmaceuticals Announces Inducement Grants to New Employees
Syndax PharmaceuticalsEmployee CompensationNASDAQBiotechnology

